Organogenesis (US:ORGO) Globenewswireยท2025-07-22 20:05Core Viewpoint - Organogenesis Holdings Inc. will report its second quarter fiscal year 2025 financial results on August 7, 2025, after market close [1] Group 1: Financial Results Announcement - The financial results for the second quarter of fiscal year 2025 will be disclosed after the market closes on August 7, 2025 [1] - A conference call will be held at 5:00 p.m. Eastern Time on the same day to discuss the results and provide a corporate update [2] Group 2: Company Overview - Organogenesis Holdings Inc. specializes in regenerative medicine, focusing on advanced wound care and surgical and sports medicine markets [3] - The company offers a comprehensive portfolio of innovative regenerative products to meet patient needs across the continuum of care [3]